Herpes gestationis
ICD-10 O26.4 is a billable code used to indicate a diagnosis of herpes gestationis.
Herpes gestationis, also known as pemphigoid gestationis, is a rare autoimmune blistering disorder that occurs during pregnancy. It typically presents in the second or third trimester and is characterized by the sudden onset of pruritic, urticarial lesions that can progress to vesicles and bullae. The lesions often begin on the abdomen and can spread to other areas, including the extremities. The condition is associated with a maternal immune response to placental antigens, leading to the production of autoantibodies that target the basement membrane of the skin. Although herpes gestationis is not directly harmful to the fetus, it can lead to complications such as preterm birth or low birth weight due to maternal discomfort and stress. Management typically involves the use of topical corticosteroids and, in more severe cases, systemic corticosteroids. Close monitoring of the mother and fetus is essential to ensure optimal outcomes.
Detailed documentation of the onset, location, and characteristics of lesions, as well as treatment plans and maternal-fetal monitoring.
A pregnant patient presents with itchy, blistering lesions on the abdomen; management includes topical steroids and monitoring for fetal well-being.
Consideration of maternal comfort and potential impacts on delivery plans.
Comprehensive documentation of maternal health status, fetal monitoring results, and any interventions required.
A high-risk pregnancy where the mother has a history of autoimmune disorders and presents with new-onset skin lesions.
Close monitoring for potential complications such as preterm labor or fetal distress.
Used during follow-up visits for management of herpes gestationis.
Document the patient's symptoms, treatment response, and any changes in condition.
Obstetricians should ensure that all relevant details are captured to support the visit.
Common treatments include topical corticosteroids for mild cases and systemic corticosteroids for more severe cases. Close monitoring of both maternal and fetal health is essential.
